The content on this site is intended for healthcare professionals only
The placebo effect in oncology trials and the criteria for approving drugs
Opinion: Premature regulatory approval by the FDA
Choosing the control arm in clinical trials
Choosing the control arm/standard of care in clinical trials
Impact of the Choosing Wisely conference in Nepal
How to read a Meta-analysis?
Pitfalls in interpretation of clinical trials
Defining value based care for LMICs
Choosing the control arm/standard of care in clinical trials
ESMO 2022: Breast and ovarian trial analysis
ESMO 2022: Highlights, commentary and analysis
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients
